These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2259 related articles for article (PubMed ID: 17270732)

  • 1. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.
    Yoshiyama Y; Higuchi M; Zhang B; Huang SM; Iwata N; Saido TC; Maeda J; Suhara T; Trojanowski JQ; Lee VM
    Neuron; 2007 Feb; 53(3):337-51. PubMed ID: 17270732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurodegeneration and inflammation: analysis of a FTDP-17 model mouse].
    Yoshiyama Y
    Rinsho Shinkeigaku; 2008 Nov; 48(11):910-2. PubMed ID: 19198115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
    Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
    Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
    Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
    Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.
    Wang L; Liu M; Gao J; Smith AM; Fujioka H; Liang J; Perry G; Wang X
    J Alzheimers Dis; 2021; 84(3):1057-1069. PubMed ID: 34602490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning.
    Eckenweber F; Medina-Luque J; Blume T; Sacher C; Biechele G; Wind K; Deussing M; Briel N; Lindner S; Boening G; von Ungern-Sternberg B; Unterrainer M; Albert NL; Zwergal A; Levin J; Bartenstein P; Cumming P; Rominger A; Höglinger GU; Herms J; Brendel M
    J Neuroinflammation; 2020 Jul; 17(1):208. PubMed ID: 32660586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
    Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
    J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.
    Zhang Z; Song M; Liu X; Kang SS; Kwon IS; Duong DM; Seyfried NT; Hu WT; Liu Z; Wang JZ; Cheng L; Sun YE; Yu SP; Levey AI; Ye K
    Nat Med; 2014 Nov; 20(11):1254-62. PubMed ID: 25326800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration.
    Forman MS; Lal D; Zhang B; Dabir DV; Swanson E; Lee VM; Trojanowski JQ
    J Neurosci; 2005 Apr; 25(14):3539-50. PubMed ID: 15814784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model.
    Yoshiyama Y; Uryu K; Higuchi M; Longhi L; Hoover R; Fujimoto S; McIntosh T; Lee VM; Trojanowski JQ
    J Neurotrauma; 2005 Oct; 22(10):1134-41. PubMed ID: 16238489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.
    Dejanovic B; Huntley MA; De Mazière A; Meilandt WJ; Wu T; Srinivasan K; Jiang Z; Gandham V; Friedman BA; Ngu H; Foreman O; Carano RAD; Chih B; Klumperman J; Bakalarski C; Hanson JE; Sheng M
    Neuron; 2018 Dec; 100(6):1322-1336.e7. PubMed ID: 30392797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.
    Ishihara T; Hong M; Zhang B; Nakagawa Y; Lee MK; Trojanowski JQ; Lee VM
    Neuron; 1999 Nov; 24(3):751-62. PubMed ID: 10595524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
    Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
    Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 113.